Semin Immunol (2022) 101603
Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved
Step 3 - Massage gently over the skin for 1 minute
While not explicitly approved by the FDA to do so, Wellbutrin may also be prescribed to help with attention deficit hyperactivity disorder (ADHD), anxiety, post-traumatic stress disorder (PTSD), anxiety and social anxiety, obesity, certain types of nerve pain, and bipolar depression, says Eleanor Health and WebMD
RedundantPEG-MGF is just a longer-acting version of MGF
Conclusion In conclusion, our study found that GLP-1RA use was associated with a statistically significant increase in hazard of hypersomnolence at both 1- and 5-year endpoints
